查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968121

全球儿童灌注产品市场规模、份额、趋势和成长分析报告（2026-2034）

Global Pediatric Perfusion Products Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计儿童灌注产品市场将从 2025 年的 2.2504 亿美元成长到 2034 年的 4.4093 亿美元，2026 年至 2034 年的复合年增长率为 7.76%。

由于先天性心臟疾病病例数量不断增加以及全球儿童心血管手术数量的增长，儿童灌注产品的全球市场正稳步增长。氧合器、帮浦和管路系统等灌注产品对于在复杂的心血管手术中维持循环至关重要。新生儿和儿童医疗保健基础设施的改善，尤其是在开发中国家，大大促进了这一专业医疗领域的扩张。

成长要素包括专为婴幼儿设计的微型灌注系统的技术进步。人们对早期诊断重要性的认识不断提高，以及手术成功率的提升，正促使医疗机构采用先进的灌註解决方案。政府针对儿童医疗保健的措施和扩大保险覆盖范围的措施也进一步推动了市场成长。此外，对专业心臟护理中心的投资增加，也有助于提升全球的手术能力。

由于不断创新，儿童心血管手术的安全性和效率持续提升，未来成长前景十分乐观。生物相容性材料的研发和监测技术的改进将有助于改善患者预后。新兴市场医疗保健服务的普及预计将带动手术数量的成长。随着医疗系统日益重视儿童健康和先进的外科上的照护，儿童灌注产品市场预计将持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球儿童灌流产品市场：依产品划分

  • 市场分析、洞察与预测
  • 儿童氧合装置
  • 儿童动脉滤器
  • 儿童套管
  • 血液浓缩器
  • 储存
  • 其他的

第五章 全球儿童灌流产品市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 专科诊所
  • 其他的

第六章 全球儿童灌流产品市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic
    • Terumo Cardiovascular Systems Corporation
    • LivaNova PLC
    • BL Lifesciences
    • Cardinal Health
    • Getinge AB
    • Eurosets
    • Edwards Lifesciences Corporation
    • Berlin Heart
    • Sorin Group
简介目录
Product Code: VMR112110249

The Pediatric Perfusion Products Market size is expected to reach USD 440.93 Million in 2034 from USD 225.04 Million (2025) growing at a CAGR of 7.76% during 2026-2034.

The Global Pediatric Perfusion Products Market is growing steadily due to rising cases of congenital heart defects and increasing pediatric cardiac surgeries worldwide. Perfusion products, including oxygenators, pumps, and tubing systems, are essential for maintaining circulation during complex heart procedures. Improvements in neonatal and pediatric healthcare infrastructure, particularly in developing economies, are significantly contributing to the expansion of this specialized medical segment.

Growth drivers include technological advancements in miniaturized perfusion systems designed specifically for infants and children. Increasing awareness about early diagnosis and improved surgical success rates are encouraging healthcare providers to adopt advanced perfusion solutions. Government initiatives focused on pediatric healthcare and expanding insurance coverage are further strengthening market growth. Moreover, rising investments in specialized cardiac care centers are enhancing procedural capabilities globally.

Future growth prospects appear promising as innovations continue to improve safety and efficiency in pediatric cardiac surgeries. Development of biocompatible materials and improved monitoring technologies will support better patient outcomes. Expanding healthcare access in emerging markets is expected to increase surgical volumes. As healthcare systems prioritize child health and advanced surgical care, the pediatric perfusion products market is poised for sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Pediatric Oxygenators
  • Pediatric Arterial Filters
  • Pediatric Cannulae
  • Hemoconcentrators
  • Reservoirs
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Others

COMPANIES PROFILED

  • Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, Eurosets, Edwards Lifesciences Corporation, Berlin Heart, Sorin Group
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Pediatric Oxygenators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Pediatric Arterial Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pediatric Cannulae Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Hemoconcentrators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Reservoirs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PEDIATRIC PERFUSION PRODUCTS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Terumo Cardiovascular Systems Corporation
    • 8.2.3 LivaNova PLC
    • 8.2.4 BL Lifesciences
    • 8.2.5 Cardinal Health
    • 8.2.6 Getinge AB
    • 8.2.7 Eurosets
    • 8.2.8 Edwards Lifesciences Corporation
    • 8.2.9 Berlin Heart
    • 8.2.10 Sorin Group